Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Outcomes of Unselected Patients With Metastatic Clear Cell RCC Treated With Front-Line Pazopanib Followed by VEGFR-TKI or mTOR Inhibitors
- Current Perspectives on Rx Sequencing for RCC: 1. Role of mTOR Inhibitors and Cabozantinib
- Current Perspectives on Rx Sequencing for RCC: 2. Combination Therapy Vis-à-Vis Toxicity
- Current Perspectives on Rx Sequencing for RCC: 3. Is There Still a Role for IL-2?